Diagnos Laboratorium Utama Tbk. vs Pudjiadi & Sons Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 308B, 42.6K 24h volume), while Pudjiadi & Sons Tbk. trades at Rp500 (market cap 398.91B, 7.5K 24h volume). The key difference: Pudjiadi & Sons Tbk. is the larger of the two by market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (42.6K versus 7.5K). Which is the better fit depends on your goals.
| DGNS | PNSE | |
|---|---|---|
Market Cap | 308B | 398.91B |
Volume | 42.6K | 7.5K |
Lot | 426 | 75 |
Turnover | 9.61M | 3.75M |
Average Price | 225.66 | 500.47 |
Value | 9.61M | 3.75M |
Indicative Equilibrium Price | 230 | 515 |
Indicative Equilibrium Volume | 110 | 2 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →PT Pudjiadi and Sons Tbk was established based on Notarial Deed No. 34 dated December 17, 1970 of Ridwan Suselo, s.h., notaris in Jakarta. Hotel business with all the facilities and infrastructures, such as , accommodation, office, shopping mall, apartment, recreation place and entertainment in the location of hotel. The Company is the owner of Jayakarta Hotel, a four star hotel.
Read more on PNSE →